Advisors Asset Management, Inc.

Position in PTCT — Ptc Therapeutics, Inc.

CIK 1297376 Monument, CO

Position in PTCT

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$1,246,389

+$630,086 QoQ

Shares Held

15,280

+68.9% QoQ

Ownership

0.018%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

#165

of 380 holders

Holding Since

Jun 2020

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Advisors Asset Management, Inc. holds $39,929,265 across 31 Biotechnology names. PTCT ranks #8 (3.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	25,909	$12,869,777
2	LGND	Ligand Pharmaceuticals Inc	17,228	$5,445,598
3	INCY	Incyte Corp	24,359	$2,761,336
4	ARQT	Arcutis Biotherapeutics, Inc.	95,934	$2,515,389
5	ASND	Ascendis Pharma A/S	9,146	$2,439,421
6	RYTM	Rhythm Pharmaceuticals, Inc.	21,896	$2,431,112
7	REGN	Regeneron Pharmaceuticals, Inc.	2,379	$1,483,401
8	PTCT	Ptc Therapeutics, Inc. This page	15,280	$1,246,389

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,246,389	15,280	+68.9%	Shares	Sole	2026-08-14
2026-03-31	$616,303	9,046	+21.3%	Shares	Sole	2026-05-15
2025-12-31	$566,661	7,460	+28.1%	Shares	Sole	2026-02-12
2022-09-30	$292,264	5,822	-5.5%	Shares	Sole	2022-11-08
2022-06-30	$246,889	6,163	-33.4%	Shares	Sole	2022-08-08
2022-03-31	$345,005	9,247	-12.6%	Shares	Sole	2022-05-17
2021-12-31	$421,600	10,585	-2.6%	Shares	Sole	2022-02-15
2021-09-30	$404,472	10,870	+0.1%	Shares	Sole	2021-11-12
2021-06-30	$459,052	10,860	+1.5%	Shares	Sole	2021-07-30
2021-03-31	$506,834	10,704	+27.3%	Shares	Sole	2021-05-07
2020-12-31	$513,018	8,406	+148.0%	Shares	Sole	2021-02-12
2020-09-30	$158,435	3,389	+86.3%	Shares	Sole	2020-11-16
2020-06-30	$92,296	1,819	—	Shares	Sole	2020-08-12
No filing history on record for this holder in this stock.